• Lipocine CEO and director Mahesh V. Patel purchased 50,000 common shares, increasing his direct holdings to 211,495 shares.
• The purchases comprised 25,000 shares at $1.5796 each and 25,000 shares at $1.5999 each.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-051673), on November 13, 2026, and is solely responsible for the information contained therein.